科研合作
赛诺联合医疗拥有世界级的团队,团队的核心成员主要来自海内外顶尖高校的资深华人科学家和国际著名医疗设备企业的行业精英。依靠完全自主可控的核心技术与优良的设备性能,同时与学科专家们完美配合,在国际范围内已助力多家临床合作医院发表了40余篇科研成果文章。这其中包括北京协和医院,北京友谊医院,武汉汉阳医院等。同时赛诺联合医疗也肩负着多项国家级科研及研发课题,赛诺联合坚信“做到·见到”,以“精·实”的企业精神和科研理念、强大的科技研发实力与高效的临床转化能力,在未来将继续坚持科研报国信念,为把我国建设成为世界科技强国贡献力量。
研究方向
统计
影响因子
统计
Head-to-head comparison of 68Ga-DOTA-JR11 and 68Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study.
68Ga-DOTATATEand68Ga-DOT A-JR11PET/CT Imaging
基于探针
The DOT A-C PCR 4-2 peptide was purchased from CS Bio
Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG
基于TOF技术
Currently, a clinical evaluation of the whole-body PoleStar m660T OF-PET/CTs can-neris carried out[51] .The system is based on
3.63×3.63×20mm³LY SO scintillator sarranged into detector modules
(14× 14 crystals) . The detector modules are then com-bined into the total of 24 detector buckets (2x 4 detector modules) forming a four-ring scanner.The timing resolution of PoleStar is~434psFWHM.TheN EMANU 2-2007
Recent developments in time-of-flight PET
Abstract:Autoimmune pan creat it i generally results in diffuse
increased FDG atiytiougoutthepinTes on PET CTi age.We peta cse of focal autoimmune pancreatitis with abn oral FDG activity involving only the pancreatic a il on PET/CTina6l-year-oldman who was pro vii on ally diag-nosedas having pancreatic cancer based on the CT find ngs.The diagnosis of au lo immune pan crea ii was based on pathological exam in at on and clev a led serumimmunogo-bunG4kvl. Following the steroid the npy,the paintwasgradually recovered.Key Words:cancer, FDG, PET/CT, type l autoimmune pane re at it is (Clin Nucl Med 2018; 43:57-59)
Qing qing Pan · Xinxin Cao · Yaping Luo · Jian Li · JunFeng ·
FangLi
Chemokine receptor -4 targeted PET/CT with68Ga-Pentix
a for in assessment of newly diagnosed multiple myeloma:comparison to 18F-FDG PET/CT
Focal Autoimmune Pancreatitis Mimicking Pancreatic Cancer on FDG PET/CT Imaging
Received:3 July 2019 / Accepted:7 November 2019/Publishedonline:
27 November 2019© Springer-Verlag GmbH Germany, part of Springer Nature 2019
Jie Ding.MD,Ling Wang.MD,PhD,Shu Zhang.MD.Fan gLi MD,and Li Huo,MD,PhD
Recurrent/Residual Intracranial Phos phat uric Mesenchymal
Tumor Revealed on68Ga-DOT A TATE PET/CT
神经
1,2
1,2
3
3
1,2
3
INTERESTING IMAGE
体部及全身动态
@2022 赛诺联合医疗科技(北京)有限公司
北京海淀区永泰庄北路1号中关村东升国际科学园1号楼C座
邮编:100192
工作时间: 周一到周五 9:00-18:00
扫码获取更多咨讯